Clinical Trial Update: Pharmacokinetics of Efavirenz in the Presence of Rifampicin and Isoniazid [Phase 1]

View source ↗

Summary

Phase 1 study assessing how rifampicin and isoniazid alter the pharmacokinetics of efavirenz in people with HIV.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection

Drugs mentioned

• ISONIAZID (ISONIAZID)
• Rifampicin
• Sustiva (efavirenz)

Snippet

Sponsor: St Stephens Aids Trust | Conditions: HIV | Phase 1 | Status: UNKNOWN